APO Research, Inc.

APO RESEARCH · REPORT

Fukangning Tablets

Selected research

Market Structure

Global Fukangning Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Fukangning Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Fukangning Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fukangning Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fukangning Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Fukangning Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fukangning Tablets include Yili Pharmaceutical (Nanning) Co., Ltd., Yantai Bohai Pharmaceutical Group Co., Ltd., Tonghua Baixin Pharmaceutical Co., Ltd., Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd., Shaanxi Panlong Pharmaceutical Group Co., Ltd., Shaanxi Kanghui Pharmaceutical Co., Ltd., Sanmenxia Guangyu Biopharmaceutical Co., Ltd., Liaoning Dongfangren Pharmaceutical Co., Ltd. and Lanzhou Weici Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fukangning Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fukangning Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fukangning Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fukangning Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Fukangning Tablets Segment by Company

Yili Pharmaceutical (Nanning) Co., Ltd.

Yantai Bohai Pharmaceutical Group Co., Ltd.

Tonghua Baixin Pharmaceutical Co., Ltd.

Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd.

Shaanxi Panlong Pharmaceutical Group Co., Ltd.

Shaanxi Kanghui Pharmaceutical Co., Ltd.

Sanmenxia Guangyu Biopharmaceutical Co., Ltd.

Liaoning Dongfangren Pharmaceutical Co., Ltd.

Lanzhou Weici Pharmaceutical Co., Ltd.

Lanzhou Foci Pharmaceutical Co., Ltd.

Jinhua Kangshou Pharmaceutical Co., Ltd.

Jiangsu Yihai Pharmaceutical Co., Ltd.

Jilin Jurentang Pharmaceutical Co., Ltd.

Huaihua Zhenghao Pharmaceutical Co., Ltd.

Henan Zhongjing Pharmaceutical Co., Ltd.

Guangzhou Xiangxue Pharmaceutical Co., Ltd.

Guangxi Weiwe Pharmaceutical Co., Ltd.

Guangxi Shuangyi Pharmaceutical Co., Ltd.

Guangxi Jinsuozi Pharmaceutical Co., Ltd.

Guangxi Fanglue Pharmaceutical Group Co., Ltd.

Guangxi Bangqi Pharmaceutical Group Co., Ltd.

Fukangning Tablets Segment by Type

Film-coated Tablets

Sugar-coated Tablets

Fukangning Tablets Segment by Application

Hospital

Clinic

Other

Fukangning Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fukangning Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fukangning Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fukangning Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fukangning Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fukangning Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fukangning Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Fukangning Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Fukangning Tablets Industry Trends Table 2. Fukangning Tablets Industry Drivers Table 3. Fukangning Tablets Industry Opportunities and Challenges Table 4. Fukangning Tablets Industry Restraints Table 5. Global Fukangning Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Fukangning Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Fukangning Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Fukangning Tablets Sales Market Share by Manufacturers Table 9. Global Fukangning Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Fukangning Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Fukangning Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Fukangning Tablets Manufacturers, Product Type & Application Table 13. Global Fukangning Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Fukangning Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Film-coated Tablets Table 17. Major Manufacturers of Sugar-coated Tablets Table 18. Global Fukangning Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Fukangning Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Fukangning Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Fukangning Tablets Sales Market Share by Type (2021-2026) Table 22. Global Fukangning Tablets Sales Market Share by Type (2027-2032) Table 23. Global Fukangning Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Fukangning Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Fukangning Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Fukangning Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Fukangning Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Fukangning Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Fukangning Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Fukangning Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Fukangning Tablets Sales Market Share by Application (2021-2026) Table 35. Global Fukangning Tablets Sales Market Share by Application (2027-2032) Table 36. Global Fukangning Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Fukangning Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Fukangning Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Fukangning Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Fukangning Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Fukangning Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Fukangning Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Fukangning Tablets Sales Market Share by Region (2021-2026) Table 44. Global Fukangning Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Fukangning Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Fukangning Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Fukangning Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Fukangning Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Fukangning Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Fukangning Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Fukangning Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Fukangning Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Fukangning Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Fukangning Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Fukangning Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Fukangning Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Fukangning Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Fukangning Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Fukangning Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Fukangning Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Fukangning Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Fukangning Tablets Revenue Market Share by Region (2027-2032) Table 63. Yili Pharmaceutical (Nanning) Co., Ltd. Company Information Table 64. Yili Pharmaceutical (Nanning) Co., Ltd. Business Overview Table 65. Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Product Portfolio Table 67. Yili Pharmaceutical (Nanning) Co., Ltd. Recent Development Table 68. Yantai Bohai Pharmaceutical Group Co., Ltd. Company Information Table 69. Yantai Bohai Pharmaceutical Group Co., Ltd. Business Overview Table 70. Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio Table 72. Yantai Bohai Pharmaceutical Group Co., Ltd. Recent Development Table 73. Tonghua Baixin Pharmaceutical Co., Ltd. Company Information Table 74. Tonghua Baixin Pharmaceutical Co., Ltd. Business Overview Table 75. Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 77. Tonghua Baixin Pharmaceutical Co., Ltd. Recent Development Table 78. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Company Information Table 79. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Business Overview Table 80. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 82. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Recent Development Table 83. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information Table 84. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Business Overview Table 85. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio Table 87. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Recent Development Table 88. Shaanxi Kanghui Pharmaceutical Co., Ltd. Company Information Table 89. Shaanxi Kanghui Pharmaceutical Co., Ltd. Business Overview Table 90. Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 92. Shaanxi Kanghui Pharmaceutical Co., Ltd. Recent Development Table 93. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information Table 94. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Business Overview Table 95. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 97. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Development Table 98. Liaoning Dongfangren Pharmaceutical Co., Ltd. Company Information Table 99. Liaoning Dongfangren Pharmaceutical Co., Ltd. Business Overview Table 100. Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 102. Liaoning Dongfangren Pharmaceutical Co., Ltd. Recent Development Table 103. Lanzhou Weici Pharmaceutical Co., Ltd. Company Information Table 104. Lanzhou Weici Pharmaceutical Co., Ltd. Business Overview Table 105. Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 107. Lanzhou Weici Pharmaceutical Co., Ltd. Recent Development Table 108. Lanzhou Foci Pharmaceutical Co., Ltd. Company Information Table 109. Lanzhou Foci Pharmaceutical Co., Ltd. Business Overview Table 110. Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 112. Lanzhou Foci Pharmaceutical Co., Ltd. Recent Development Table 113. Jinhua Kangshou Pharmaceutical Co., Ltd. Company Information Table 114. Jinhua Kangshou Pharmaceutical Co., Ltd. Business Overview Table 115. Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 117. Jinhua Kangshou Pharmaceutical Co., Ltd. Recent Development Table 118. Jiangsu Yihai Pharmaceutical Co., Ltd. Company Information Table 119. Jiangsu Yihai Pharmaceutical Co., Ltd. Business Overview Table 120. Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 122. Jiangsu Yihai Pharmaceutical Co., Ltd. Recent Development Table 123. Jilin Jurentang Pharmaceutical Co., Ltd. Company Information Table 124. Jilin Jurentang Pharmaceutical Co., Ltd. Business Overview Table 125. Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 127. Jilin Jurentang Pharmaceutical Co., Ltd. Recent Development Table 128. Huaihua Zhenghao Pharmaceutical Co., Ltd. Company Information Table 129. Huaihua Zhenghao Pharmaceutical Co., Ltd. Business Overview Table 130. Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 132. Huaihua Zhenghao Pharmaceutical Co., Ltd. Recent Development Table 133. Henan Zhongjing Pharmaceutical Co., Ltd. Company Information Table 134. Henan Zhongjing Pharmaceutical Co., Ltd. Business Overview Table 135. Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 137. Henan Zhongjing Pharmaceutical Co., Ltd. Recent Development Table 138. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Company Information Table 139. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Business Overview Table 140. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 142. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Recent Development Table 143. Guangxi Weiwe Pharmaceutical Co., Ltd. Company Information Table 144. Guangxi Weiwe Pharmaceutical Co., Ltd. Business Overview Table 145. Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 147. Guangxi Weiwe Pharmaceutical Co., Ltd. Recent Development Table 148. Guangxi Shuangyi Pharmaceutical Co., Ltd. Company Information Table 149. Guangxi Shuangyi Pharmaceutical Co., Ltd. Business Overview Table 150. Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 152. Guangxi Shuangyi Pharmaceutical Co., Ltd. Recent Development Table 153. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Company Information Table 154. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Business Overview Table 155. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio Table 157. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Recent Development Table 158. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Company Information Table 159. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Business Overview Table 160. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio Table 162. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Recent Development Table 163. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Company Information Table 164. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Business Overview Table 165. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio Table 167. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Fukangning Tablets Distributors List Table 171. Fukangning Tablets Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Fukangning Tablets Product Image Figure 2. Global Fukangning Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fukangning Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Fukangning Tablets Sales (2021-2032) & (K Units) Figure 5. Global Fukangning Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Fukangning Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Film-coated Tablets Image Figure 9. Sugar-coated Tablets Image Figure 10. Global Fukangning Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Fukangning Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Fukangning Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Fukangning Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Fukangning Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Fukangning Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Fukangning Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Fukangning Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Fukangning Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Fukangning Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Fukangning Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Fukangning Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Fukangning Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Fukangning Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Fukangning Tablets Sales Market Share by Country (2021-2032) Figure 39. China Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Fukangning Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Fukangning Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Fukangning Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Fukangning Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Fukangning Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Fukangning Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Fukangning Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Fukangning Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Fukangning Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Fukangning Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Fukangning Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Fukangning Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Fukangning Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Fukangning Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Film-coated Tablets
  • Sugar-coated Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yili Pharmaceutical (Nanning) Co., Ltd.
  • Yantai Bohai Pharmaceutical Group Co., Ltd.
  • Tonghua Baixin Pharmaceutical Co., Ltd.
  • Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd.
  • Shaanxi Panlong Pharmaceutical Group Co., Ltd.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd.
  • Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
  • Liaoning Dongfangren Pharmaceutical Co., Ltd.
  • Lanzhou Weici Pharmaceutical Co., Ltd.
  • Lanzhou Foci Pharmaceutical Co., Ltd.
  • Jinhua Kangshou Pharmaceutical Co., Ltd.
  • Jiangsu Yihai Pharmaceutical Co., Ltd.
  • Jilin Jurentang Pharmaceutical Co., Ltd.
  • Huaihua Zhenghao Pharmaceutical Co., Ltd.
  • Henan Zhongjing Pharmaceutical Co., Ltd.
  • Guangzhou Xiangxue Pharmaceutical Co., Ltd.
  • Guangxi Weiwe Pharmaceutical Co., Ltd.
  • Guangxi Shuangyi Pharmaceutical Co., Ltd.
  • Guangxi Jinsuozi Pharmaceutical Co., Ltd.
  • Guangxi Fanglue Pharmaceutical Group Co., Ltd.
  • Guangxi Bangqi Pharmaceutical Group Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fukangning Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fukangning Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Fukangning Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Fukangning Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Fukangning Tablets Market Dynamics
  1. 2.1 Fukangning Tablets Industry Trends
  2. 2.2 Fukangning Tablets Industry Drivers
  3. 2.3 Fukangning Tablets Industry Opportunities and Challenges
  4. 2.4 Fukangning Tablets Industry Restraints
3 Fukangning Tablets Market by Manufacturers
  1. 3.1 Global Fukangning Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Fukangning Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Fukangning Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Fukangning Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fukangning Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Fukangning Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Fukangning Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fukangning Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fukangning Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fukangning Tablets Tier 1, Tier 2, and Tier 3
4 Fukangning Tablets Market by Type
  1. 4.1 Fukangning Tablets Type Introduction
  2. 4.1.1 Film-coated Tablets
  3. 4.1.2 Sugar-coated Tablets
  4. 4.2 Global Fukangning Tablets Sales by Type
  5. 4.2.1 Global Fukangning Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fukangning Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Fukangning Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Fukangning Tablets Revenue by Type
  9. 4.3.1 Global Fukangning Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fukangning Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Fukangning Tablets Revenue Market Share by Type (2021-2032)
5 Fukangning Tablets Market by Application
  1. 5.1 Fukangning Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Fukangning Tablets Sales by Application
  6. 5.2.1 Global Fukangning Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fukangning Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Fukangning Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Fukangning Tablets Revenue by Application
  10. 5.3.1 Global Fukangning Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fukangning Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Fukangning Tablets Revenue Market Share by Application (2021-2032)
6 Global Fukangning Tablets Sales by Region
  1. 6.1 Global Fukangning Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fukangning Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Fukangning Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Fukangning Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fukangning Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Fukangning Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Fukangning Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Fukangning Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Fukangning Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Fukangning Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Fukangning Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Fukangning Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Fukangning Tablets Revenue by Region
  1. 7.1 Global Fukangning Tablets Revenue by Region
  2. 7.1.1 Global Fukangning Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Fukangning Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Fukangning Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Fukangning Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Fukangning Tablets Revenue (2021-2032)
  8. 7.2.2 North America Fukangning Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Fukangning Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Fukangning Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Fukangning Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Fukangning Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Fukangning Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Fukangning Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yili Pharmaceutical (Nanning) Co., Ltd.
  2. 8.1.1 Yili Pharmaceutical (Nanning) Co., Ltd. Company Information
  3. 8.1.2 Yili Pharmaceutical (Nanning) Co., Ltd. Business Overview
  4. 8.1.3 Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Product Portfolio
  6. 8.1.5 Yili Pharmaceutical (Nanning) Co., Ltd. Recent Developments
  7. 8.2 Yantai Bohai Pharmaceutical Group Co., Ltd.
  8. 8.2.1 Yantai Bohai Pharmaceutical Group Co., Ltd. Company Information
  9. 8.2.2 Yantai Bohai Pharmaceutical Group Co., Ltd. Business Overview
  10. 8.2.3 Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
  12. 8.2.5 Yantai Bohai Pharmaceutical Group Co., Ltd. Recent Developments
  13. 8.3 Tonghua Baixin Pharmaceutical Co., Ltd.
  14. 8.3.1 Tonghua Baixin Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Tonghua Baixin Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  18. 8.3.5 Tonghua Baixin Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd.
  20. 8.4.1 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  24. 8.4.5 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Shaanxi Panlong Pharmaceutical Group Co., Ltd.
  26. 8.5.1 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information
  27. 8.5.2 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Business Overview
  28. 8.5.3 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
  30. 8.5.5 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Recent Developments
  31. 8.6 Shaanxi Kanghui Pharmaceutical Co., Ltd.
  32. 8.6.1 Shaanxi Kanghui Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shaanxi Kanghui Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  36. 8.6.5 Shaanxi Kanghui Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
  38. 8.7.1 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  42. 8.7.5 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Liaoning Dongfangren Pharmaceutical Co., Ltd.
  44. 8.8.1 Liaoning Dongfangren Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Liaoning Dongfangren Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  48. 8.8.5 Liaoning Dongfangren Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Lanzhou Weici Pharmaceutical Co., Ltd.
  50. 8.9.1 Lanzhou Weici Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Lanzhou Weici Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  54. 8.9.5 Lanzhou Weici Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Lanzhou Foci Pharmaceutical Co., Ltd.
  56. 8.10.1 Lanzhou Foci Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Lanzhou Foci Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  60. 8.10.5 Lanzhou Foci Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Jinhua Kangshou Pharmaceutical Co., Ltd.
  62. 8.11.1 Jinhua Kangshou Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Jinhua Kangshou Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  66. 8.11.5 Jinhua Kangshou Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Jiangsu Yihai Pharmaceutical Co., Ltd.
  68. 8.12.1 Jiangsu Yihai Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Jiangsu Yihai Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  72. 8.12.5 Jiangsu Yihai Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jilin Jurentang Pharmaceutical Co., Ltd.
  74. 8.13.1 Jilin Jurentang Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jilin Jurentang Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  78. 8.13.5 Jilin Jurentang Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Huaihua Zhenghao Pharmaceutical Co., Ltd.
  80. 8.14.1 Huaihua Zhenghao Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Huaihua Zhenghao Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  84. 8.14.5 Huaihua Zhenghao Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Henan Zhongjing Pharmaceutical Co., Ltd.
  86. 8.15.1 Henan Zhongjing Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Henan Zhongjing Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  90. 8.15.5 Henan Zhongjing Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Guangzhou Xiangxue Pharmaceutical Co., Ltd.
  92. 8.16.1 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  96. 8.16.5 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Guangxi Weiwe Pharmaceutical Co., Ltd.
  98. 8.17.1 Guangxi Weiwe Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Guangxi Weiwe Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  102. 8.17.5 Guangxi Weiwe Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Guangxi Shuangyi Pharmaceutical Co., Ltd.
  104. 8.18.1 Guangxi Shuangyi Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Guangxi Shuangyi Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  108. 8.18.5 Guangxi Shuangyi Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Guangxi Jinsuozi Pharmaceutical Co., Ltd.
  110. 8.19.1 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
  114. 8.19.5 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Guangxi Fanglue Pharmaceutical Group Co., Ltd.
  116. 8.20.1 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Company Information
  117. 8.20.2 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Business Overview
  118. 8.20.3 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
  120. 8.20.5 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Recent Developments
  121. 8.21 Guangxi Bangqi Pharmaceutical Group Co., Ltd.
  122. 8.21.1 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Company Information
  123. 8.21.2 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Business Overview
  124. 8.21.3 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
  126. 8.21.5 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fukangning Tablets Value Chain Analysis
  2. 9.1.1 Fukangning Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fukangning Tablets Production Mode & Process
  6. 9.2 Fukangning Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fukangning Tablets Distributors
  9. 9.2.3 Fukangning Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.